The Hyderabad based leading pharma company Aurobindo Pharma Ltd has received approval from the US FDA for terbinafine hydrochloride tablets 250 mg. This approval is received on the first day after the expiry of the relevant patent.

Terbinafine hydrochloride tablets 250 mg is the generic equivalent of Novartis anti fungal Lamisil tablets. The brand product has annual sales of approximately USD 654 million in US.